Reply

Filiaciones

Torres-Valle A.:

Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain

Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC – University of Salamanca), University of Salamanca, Salamanca, Spain

Department of Medicine, University of Salamanca, Salamanca, Spain

Neirinck J.:

Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium

Silva S.L.:

Serviço de Imunoalergologia, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal

Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

GIMM – Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal

de Arriba S.:

Pediatrics Department, University Hospital of Salamanca, Salamanca, Spain

Serrano C.:

Servicio de Inmunología, Fundación Jiménez Díaz, Madrid, Spain

Cordón L.:

Instituto de Investigación. Hematology Research Group, Instituto de Investigación Sanitaria La Fe, València, Spain

Biomedical Research Networking Centre Consortium of Oncology (no. CB16/12/00284), Instituto de Salud Carlos III, Madrid, Spain

Arenas-Caro P.P.:

Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain

Subirá D.:

Flow Cytometry Unit, Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara, Spain

Mercado M.R.:

Hospital Universitario Costa del Sol, Hematologia y Hemoterapia, Marbella, Spain

González Granado L.I.:

Immunodeficiencies Unit, Hospital 12 de octubre Research Institute Hospital 12 octubre (i+12), Madrid, Spain

Martins C.:

CHRC, NOVA Medical School/Faculdade de Ciências Médicas Universidade Nova de Lisboa, Lisboa, Portugal

Kalina T.:

CLIP, Department of Haematology/Oncology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic

Balastegui-Martín H.:

PID Unit, Internal Medicine Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Cabanero-Navalon M.D.:

PID Unit, Internal Medicine Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Marcos M.:

Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain

Department of Medicine, University of Salamanca, Salamanca, Spain

Ines S.:

Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain

Department of Medicine, University of Salamanca, Salamanca, Spain

Contreras T.:

Servicio de Bioquímica Clínica, Hospital Universitario de Salamanca, Salamanca, Spain

Prieto C.:

Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

Bioinformatics service (NUCLEUS), University of Salamanca, Salamanca, Spain

García Cañadas M.C.:

Hospital Universitario Costa del Sol, Hematologia y Hemoterapia, Marbella, Spain

Cordeiro A.I.:

Primary Immunodeficiencies Unit, Hospital D. Estefânia, Unidade Local de Saúde São José, Lisbon, Portugal

Albarran B.:

Servicio de Hematología, Complejo Asistencial Universitario, León, Spain

González Gómez N.:

Servicio de Hematología, Hospital Obispo Polanco, Teruel, Spain

Hurtado G.:

Servicio de Hematología, Hospital Universitario de Navarra, Pamplona, Spain

Barez A.:

Department of Hematology, Complejo Asistencial de Ávila, Ávila, Spain

Madruga I.:

Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain

Department of Medicine, University of Salamanca, Salamanca, Spain

García-Sancho A.M.:

Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain

Servicio de Hematología, Hospital Universitario de Salamanca, Institute for Biomedical Research of Salamanca, Salamanca, Spain

Biomedical Research Networking Centre Consortium of Oncology (no. CB/16/12/00233), Instituto de Salud Carlos III, Salamanca, Spain

Bastida J.M.:

Servicio de Hematología, Hospital Universitario de Salamanca, Institute for Biomedical Research of Salamanca, Salamanca, Spain

Biomedical Research Networking Centre Consortium of Oncology (no. CB/16/12/00233), Instituto de Salud Carlos III, Salamanca, Spain

Davila I.:

Servicio de Alergia, Hospital Universitario de Salamanca, Institute for Biomedical Research of Salamanca, Biomedical and Diagnosis Science Department, University of Salamanca, Salamanca, Spain

Aragon L.:

Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain

Requejo Olaizola P.M.:

Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain

Hofmans M.:

Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium

De Vriendt C.:

Department of Hematology, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium

Blanco E.:

Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain

Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC – University of Salamanca), University of Salamanca, Salamanca, Spain

Department of Medicine, University of Salamanca, Salamanca, Spain

Jara-Acevedo M.:

Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

DNA Sequencing Service (NUCLEUS), University of Salamanca, Salamanca, Spain

Biomedical Research Networking Centre Consortium of Oncology (no. CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain

Kerre T.:

Department of Hematology, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium

Sempere A.:

Biomedical Research Networking Centre Consortium of Oncology (no. CB16/12/00284), Instituto de Salud Carlos III, Madrid, Spain

Hematology and Hemotherapy Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Haerynck F.:

Primary Immunodeficiency Research Lab, Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Ghent, Belgium

Prada Á.:

Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain

Sousa A.E.:

Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

GIMM – Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal

Bonroy C.:

Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium

Department of Diagnostic Sciences, Ghent University, Ghent, Belgium

van Dongen J.J.M.:

Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain

Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC – University of Salamanca), University of Salamanca, Salamanca, Spain

Department of Medicine, University of Salamanca, Salamanca, Spain

Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

Pérez-Andrés M.:

Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain

Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC – University of Salamanca), University of Salamanca, Salamanca, Spain

Department of Medicine, University of Salamanca, Salamanca, Spain

Biomedical Research Networking Centre Consortium of Oncology (no. CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain

Orfao A.:

Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain

Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain

Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC – University of Salamanca), University of Salamanca, Salamanca, Spain

Department of Medicine, University of Salamanca, Salamanca, Spain

Biomedical Research Networking Centre Consortium of Oncology (no. CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain